Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results

被引：1

作者：

Nasnas, Patrice ^{[1
]}

Jabbour, Elias ^{[1
]}

Short, Nicholas ^{[1
]}

Sasaki, Koji ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jain, Nitin ^{[2
]}

Daver, Naval ^{[1
]}

Pemmaraju, Naveen ^{[1
]}

Yilmaz, Musa ^{[2
]}

Kadia, Tapan M. ^{[2
]}

Garris, Rebecca ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Konopleva, Marina ^{[3
]}

Wierda, William G. ^{[4
]}

Kwari, Monica ^{[1
]}

Loiselle, Christopher ^{[1
]}

Milton, Anna ^{[1
]}

Rivera, Juan ^{[1
]}

Banks, Glenda ^{[1
]}

Kantarjian, Hagop ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[3] MD Anderson Canc Ctr, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-167761

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3250 / 3252

页数：3

共 50 条

[21] Outcome of Patients With Chronic Myeloid Leukemia in Lymphoid Blastic Phase and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Hyper-CVAD and Dasatinib
Morita, Kiyomi
Kantarjian, Hagop M.
Sasaki, Koji
Issa, Ghayas C.
Jain, Nitin
Konopleva, Marina
Short, Nicholas J.
Takahashi, Koichi
DiNardo, Courtney D.
Kadia, Tapan M.
Garcia-Manero, Guillermo
Daver, Naval
Montalban Bravo, Guillermo
Cortes, Jorge E.
Ravandi, Farhad
Jabbour, Elias
CANCER, 2021, 127 (15) : 2641 - 2647
[22] The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia
Sanford, David S.
Kantarjian, Hagop
O'Brien, Susan
Jabbour, Elias
Cortes, Jorge
Ravandi, Farhad
EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (04) : 365 - 373
[23] Propensity score analysis: Frontline therapy with hyper-CVAD (HCVAD) plus ponatinib vs. HCVAD plus dasatinib in patients (pts) with Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL).
Sasaki, Koji
Kantarjian, Hagop M.
Ravandi, Farhad
Thomas, Deborah A.
Daver, Naval Guastad
Kadia, Tapan M.
Konopleva, Marina
Jain, Nitin
Short, Nicholas James
Issa, Ghayas C.
Jeanis, Vicky
Moore, H. Gal
Garris, Rebecca S.
Garcia-Manero, Guillermo
Cortes, Jorge E.
O'Brien, Susan Mary
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[24] Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Tanimura, Kazuki
Yamasaki, Kai
Okuhiro, Yuki
Hira, Kota
Nitani, Chika
Okada, Keiko
Fujisaki, Hiroyuki
Matsumoto, Kana
Hara, Junichi
CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 24 - 28
[25] Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis
Sasaki, Koji
Kantarjian, Hagop M.
Morita, Kiyomi
Short, Nicholas J.
Konopleva, Marina
Jain, Nitin
Ravandi, Farhad
Garcia-Manero, Guillermo
Wang, Sa
Khoury, Joseph D.
Jorgensen, Jeffrey L.
Champlin, Richard E.
Khouri, Issa F.
Kebriaei, Partow
Schroeder, Heather M.
Khouri, Maria
Garris, Rebecca
Takahashi, Koichi
O'Brien, Susan M.
Jabbour, Elias J.
CANCER, 2021, 127 (18) : 3381 - 3389
[26] Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ribera, Josep-Maria
Garcia-Calduch, Olga
Ribera, Jordi
Montesinos, Pau
Cano-Ferri, Isabel
Martinez, Pilar
Esteve, Jordi
Esteban, Daniel
Garcia-Fortes, Maria
Alonso, Natalia
Gonzalez-Campos, Jose
Bermudez, Arancha
Torrent, Anna
Genesca, Eulalia
Mercadal, Santiago
Martinez-Lopez, Joaquin
Garcia-Sanz, Ramon
BLOOD ADVANCES, 2022, 6 (18) : 5395 - 5402
[27] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Narayanan, V.
Pollyea, D. A.
Gutman, J. A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
[28] Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Short, Nicholas J.
Kantarjian, Hagop
Konopleva, Marina
Desikan, Sai Prasad Prasad
Jain, Nitin
Ravandi, Farhad
Huang, Xuelin
Wierda, William G.
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas C.
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
DiNardo, Courtney D.
Thankachan, Jennifer
Delumpa, Ricardo
Milton, Anna
Jabbour, Elias J.
BLOOD, 2021, 138
[29] Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Haddad, Fadi G.
Kantarjian, Hagop
Short, Nicholas J.
Konopleva, Marina
Jain, Nitin
Huang, Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S204 - S204
[30] Prognostic Significance of IKZF1, PAX5, and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA with Dasatinib or Ponatinib
Sasaki, Yuya
Short, Nicholas J.
Kantarjian, Hagop M.
Garris, Rebecca
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina Y.
Rytting, Michael E.
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Wang, Feng
Takahashi, Koichi
Jabbour, Elias
BLOOD, 2019, 134

← 1 2 3 4 5 →